Update on clinical and laboratory features in necrobiosis lipoidica: A retrospective multicentre study of 52 patients

European Journal of Dermatology

Volumn 22, Issue 6, 2012, Pages 770-775

  Erfurt Berge, Cornelia ^a   Seitz, Anna Theresa ^b   Rehse, Corinna ^b   Wollina, Uwe ^c   Schwede, Katharina ^b   Renner, Regina ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c ACADEMIC TEACHING HOSPITAL DRESDEN FRIEDRICHSTADT   (Germany)

Author keywords

Comorbidities; Diabetes mellitus; Necrobiosis lipoidica; Thyroid disorders; Ulcer

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMORBIDITY; COMPRESSION THERAPY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); NECROBIOSIS LIPOIDICA; PATIENT ASSESSMENT; PHOTOTHERAPY; RETROSPECTIVE STUDY; SEX RATIO; SYSTEMIC THERAPY; THYROID DISEASE; ULCER; ULTRAVIOLET RADIATION;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CALCINEURIN; CHI-SQUARE DISTRIBUTION; COMPRESSION BANDAGES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LEG ULCER; MALE; MIDDLE AGED; NECROBIOSIS LIPOIDICA; RETROSPECTIVE STUDIES; SEX FACTORS; THYROID DISEASES; ULTRAVIOLET THERAPY; YOUNG ADULT;

EID: 84876352872     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2012.1839     Document Type: Article

References (34)

1. Berking C, Hegyi J, Arenberger P, Ruzicka T, Jemec GB. Photodynamic therapy of necrobiosis lipoidica-a multicenter study of 18 patients. Dermatology 2009; 218: 136-9.
2. Eberle FC, Ghoreschi K, Hertl M. Fumaric acid esters in severe ulcerative necrobiosis lipoidica: a case report and evaluation of current therapies. Acta Derm Venereol 2010; 90: 104-6.
3. Kreuter A, Knierim C, Stucker M, et al. Fumaric acid esters in necrobiosis lipoidica: results of a prospective noncontrolled study. Br J Dermatol 2005; 153: 802-7.
4. Stanway A, Rademaker M, Newman P. Healing of severe ulcerative necrobiosis lipoidica with cyclosporin. Australas J Dermatol 2004; 45: 119-22.
5. Hauner H, Koster I, von FL. [Prevalence of diabetes mellitus in Germany 1998-2001. Secondary data analysis of a health insurance sample of the AOK in Hesse/KV in Hesse]. Dtsch Med Wochenschr 2003; 128: 2632-7.
6. von FL, Salzsieder E, Hauner H, et al. Diabetes prevalence from health insurance data: evaluation of estimates by comparison with a population- based diabetes register. Diabete Metab 1993; 19: 89-95.
7. Thefeld W. [Prevalence of diabetes mellitus in the adult German population]. Gesundheitswesen 1999; 61 Spec No: S85-S89.
8. Hauner H, von FL, Koster I. [Estimation of the incidence of diabetes in the Federal Republic of Germany based on insurance data. A secondary data analysis of a representative random sample of locally insured persons in the city of Dortmund]. Dtsch Med Wochenschr 1992; 117(17): 645-50.
9. O'Toole EA, Kennedy U, Nolan JJ, Young MM, Rogers S, Barnes L. Necrobiosis lipoidica: only a minority of patients have diabetes mellitus. Br J Dermatol 1999; 140: 283-6.
10. Muller SA, Winkelmann RK. Necrobiosis lipoidica diabeticorum. A clinical and pathological investigation of 171 cases. Arch Dermatol 1966; 93: 272-81.
11. Magro CM, Crowson AN, Regauer S. Granuloma annulare and necrobiosis lipoidica tissue reactions as a manifestation of systemic disease. Hum Pathol 1996; 27: 50-6.
12. Ngo BT, Hayes KD, DiMiao DJ, Srinivasan SK, Huerter CJ, Rendell MS. Manifestations of cutaneous diabetic microangiopathy. Am J Clin Dermatol 2005; 6: 225-37.
13. Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289(18): 2363-9.
14. Mensink GB, Lampert T, Bergmann E. [Overweight and obesity in Germany 1984-2003]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2005; 48(12): 1348-56.
15. Melchert H, Görsch B, Thierfelder W. Schilddrüsenhormone und Schilddrüsenmedikamente bei Probanden in den Nationalen Gesundheitssurveys. Beiträge zur Gesundheitsberichterstattung des Bundes 2002. Robert-Koch-Institut, Berlin 2002. ISBN: 3-89606r-r138-0.
16. O'Reilly K, Chu J, Meehan S, Heller P, Ashinoff R, Gruson L. Necrobiosis lipoidica. Dermatol Online J 2011; 17(10): 18.
17. Lowitt MH, Dover JS. Necrobiosis lipoidica. J Am Acad Dermatol 1991; 25: 735-48.
18. Eisendle K, Baltaci M, Kutzner H, Zelger B. Detection of spirochaetal microorganisms by focus floating microscopy in necrobiosis lipoidica in patients from central Europe. Histopathology 2008; 52: 877-84.
19. Haralambous S, Blackwell C, Mappouras DG, Weir DM, Kemmett D, Lymberi P. Increased natural autoantibody activity to cytoskeleton proteins in sera from patients with necrobiosis lipoidica, with or without insulin-dependent diabetes mellitus. Autoimmunity 1995; 20: 267-75.
20. Morihara K, Takenaka H, Morihara T, Kishimoto S. Atypical form of necrobiosis lipoidica associated with lymphoedema. J Eur Acad Dermatol Venereol 2007; 21: 831-3.
21. Lim C, Tschuchnigg M, Lim J. Squamous cell carcinoma arising in an area of long- standing necrobiosis lipoidica. J Cutan Pathol 2006; 33: 581-3.
22. De Rie MA, Sommer A, Hoekzema R, Neumann HA. Treatment of necrobiosis lipoidica with topical psoralen plus ultraviolet A. Br J Dermatol 2002; 147: 743-7.
23. Diamond SA. Compression therapy in ulcers of necrobiosis lipodica diabeticorum. IMJ Ill Med J 1965; 128: 331-2.
24. Barth D, Harth W, Treudler R, Simon JC. [Topical tacrolimus in necrobiosis lipoidica]. Hautarzt 2011; 62: 459-62.
25. Clayton TH, Harrison PV. Successful treatment of chronic ulcerated necrobiosis lipoidica with 0.1% topical tacrolimus ointment. Br J Dermatol 2005; 152: 581-2.
26. Patsatsi A, Kyriakou A, Sotiriadis D. Necrobiosis lipoidica: early diagnosis and treatment with tacrolimus. Case Rep Dermatol 2011; 3: 89-93.
27. Narbutt J, Torzecka JD, Sysa-Jedrzejowska A, Zalewska A. Longterm results of topical PUVA in necrobiosis lipoidica. Clin Exp Dermatol 2006; 31: 65-7.
28. Köstler E, Wollina U. Ulcerated necrobiosis lipoidica: a combined treatment approach with dermatosurgery and PUVA. Int J Low Extrem Wounds 2003; 2: 243-5.
29. Basaria S, Braga-Basaria M. Necrobiosis lipoidica diabeticorum: response to pentoxiphylline. J Endocrinol Invest 2003; 26(10): 1037-40.
30. Beattie PE, Dawe RS, Ibbotson SH, Ferguson J. UVA1 phototherapy for treatment of necrobiosis lipoidica. Clin Exp Dermatol 2006; 31: 235-8.
31. Durupt F, Dalle S, Debarbieux S, Balme B, Ronger S, Thomas L. Successful treatment of necrobiosis lipoidica with antimalarial agents. Arch Dermatol 2008; 144: 118-9.
32. Kosaka S, Kawana S. Case of necrobiosis lipoidica diabeticorum successfully treated by photodynamic therapy. J Dermatol 2012; 39: 497-9.
33. Brauns B, Schon MP, Zutt M. Ulcerative necrobiosis lipoidica successfully treated by vacuum-assisted closure therapy. Eur J Dermatol 2011; 21: 791-2.
34. Suarez-Amor O, Perez-Bustillo A, Ruiz-Gonzalez I, Rodriguez- Prieto MA. Necrobiosis lipoidica therapy with biologicals: an ulcerated case responding to etanercept and a review of the literature. Dermatology 2010; 221: 117-21.